{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:47:05Z","timestamp":1790156825489,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients, especially inpatients, with spinal cord lesions and disorders (SCI\/D) have an elevated risk of recurrent urinary tract infections with multidrug resistant (MDR) bacteria. This study evaluated antimicrobial resistance and the prevalence of multidrug resistance and determined the risk factors for multidrug resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, urine culture results were used to calculate the antimicrobial resistance rate and the incidence of infection with MDR bacteria in the SCI\/D population. MDR was defined as acquired nonsusceptibility to at least one agent from three or more antimicrobial categories. The cohort included 402 inpatients from 2013 to 2020, with 1385 urine isolates. We included only the first isolate; duplicate isolates, defined as positive cultures of the same strain within 14\u00a0days, were excluded from the evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The most common MDR strains were\n                      <jats:italic>Klebsiella<\/jats:italic>\n                      spp\n                      <jats:italic>.<\/jats:italic>\n                      (29%) and\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (24%). MDR isolates were detected in 50% of the samples and extended spectrum beta-lactamase (ESBL)-producing isolates were detected in 26%, while carbapenem resistance was found in 0.1%. Significantly higher rates of infection with MDR bacteria were identified in groups of patients with indwelling urethral\/suprapubic catheters (p\u2009=\u20090.003) and severity scores of C1\u2013C4\/AIS A\u2013C (p\u2009=\u20090.01). We identified age (OR: 0.99, 95% CI; 0.98\u20130.99, p\u2009=\u20090.000), sex (OR: 1.55, 95% CI; 1.16\u20132.06, p\u2009=\u20090.003), management with urethral\/suprapubic catheters (OR: 2.76, 95% CI; 2.04\u20133.74, p\u2009=\u20090.000), and spontaneous voiding (OR: 1.84, 95% CI; 1.03\u20133.29, p\u2009=\u20090.038) as independent predictors of multidrug resistance in our study population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified a high antibiotic resistance rate and an increasing prevalence of infection with MDR bacteria in the SCI\/D inpatient population. Particular attention should be given to bladder management, with an emphasis on minimizing the use of indwelling catheters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07235-3","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T10:02:26Z","timestamp":1646820146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The prevalence of antibiotic-resistant and multidrug-resistant bacteria in urine cultures from inpatients with spinal cord injuries and disorders: an 8-year, single-center study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0081-9986","authenticated-orcid":false,"given":"Vladim\u00edr","family":"\u0160\u00e1mal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1109-8336","authenticated-orcid":false,"given":"V\u00edt","family":"Paldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"F\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3509-0988","authenticated-orcid":false,"given":"Jan","family":"Me\u010dl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1806-0998","authenticated-orcid":false,"given":"Jaroslav","family":"\u0160r\u00e1m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"7235_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/sj.sc.3101499","volume":"41","author":"J Penders","year":"2003","unstructured":"Penders J, Huylenbroeck AA, Everaert K, Van Laere M, Verschraegen GL. Urinary infections in patients with spinal cord injury. Spinal Cord. 2003;41:549\u201352.","journal-title":"Spinal Cord"},{"key":"7235_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0022-5347(05)67157-1","volume":"164","author":"A Esclarin De Ruz","year":"2000","unstructured":"Esclarin De Ruz A, Garcia Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol. 2000;164:1285\u20139.","journal-title":"J Urol"},{"key":"7235_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2340\/16501977-2166","volume":"48","author":"JJ Adriaansen","year":"2016","unstructured":"Adriaansen JJ, Ruijs LE, van Koppenhagen CF, van Asbeck FW, Snoek GJ, van Kuppevelt D, et al. Secondary health conditions and quality of life in persons living with spinal cord injury for at least ten years. J Rehabil Med. 2016;48:853\u201360.","journal-title":"J Rehabil Med"},{"key":"7235_CR4","unstructured":"Control ECfDPa. Surveillance of antimicrobial resistance in Europe 2018 [Internet]. 2020. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2018."},{"key":"7235_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.7224\/1537-2073.2016-067","volume":"19","author":"MH Rabadi","year":"2017","unstructured":"Rabadi MH, Aston CE. Predictors of mortality in veterans with multiple sclerosis in an outpatient clinic setting. Int J MS Care. 2017;19:265\u201373.","journal-title":"Int J MS Care"},{"key":"7235_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/10790268.2001.11753562","volume":"24","author":"KB Waites","year":"2001","unstructured":"Waites KB, Canupp KC, Chen Y, DeVivo MJ, Moser SA. Bacteremia after spinal cord injury in initial versus subsequent hospitalizations. J Spinal Cord Med. 2001;24:96\u2013100.","journal-title":"J Spinal Cord Med"},{"key":"7235_CR7","doi-asserted-by":"publisher","first-page":"717094","DOI":"10.1155\/2015\/717094","volume":"2015","author":"CY Hsiao","year":"2015","unstructured":"Hsiao CY, Yang HY, Chang CH, Lin HL, Wu CY, Hsiao MC, et al. Risk factors for development of septic shock in patients with urinary tract infection. Biomed Res Int. 2015;2015:717094.","journal-title":"Biomed Res Int"},{"key":"7235_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1089\/end.2012.0063","volume":"26","author":"B Welk","year":"2012","unstructured":"Welk B, Fuller A, Razvi H, Denstedt J. Renal stone disease in spinal-cord-injured patients. J Endourol. 2012;26:954\u20139.","journal-title":"J Endourol"},{"key":"7235_CR9","unstructured":"(EU-CAST) ECoASt. Clinical breakpoints - breakpoints and guidance [Internet]. 2020. Available from: https:\/\/www.eucast.org\/ast_of_bacteria\/."},{"key":"7235_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"7235_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41393-019-0393-y","volume":"58","author":"S Ramanathan","year":"2020","unstructured":"Ramanathan S, Fitzpatrick MA, Suda KJ, Burns SP, Jones MM, LaVela SL, et al. Multidrug-resistant gram-negative organisms and association with 1-year mortality, readmission, and length of stay in Veterans with spinal cord injuries and disorders. Spinal Cord. 2020;58:596\u2013608.","journal-title":"Spinal Cord"},{"key":"7235_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/10790268.2017.1281373","volume":"41","author":"MA Fitzpatrick","year":"2018","unstructured":"Fitzpatrick MA, Suda KJ, Safdar N, Burns SP, Jones MM, Poggensee L, et al. Changes in bacterial epidemiology and antibiotic resistance among veterans with spinal cord injury\/disorder over the past 9 years. J Spinal Cord Med. 2018;41:199\u2013207.","journal-title":"J Spinal Cord Med"},{"key":"7235_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sc.2016.38","volume":"54","author":"KJ Suda","year":"2016","unstructured":"Suda KJ, Patel UC, Sabzwari R, Cao L, Ramanathan S, Hill JN, et al. Bacterial susceptibility patterns in patients with spinal cord injury and disorder (SCI\/D): an opportunity for customized stewardship tools. Spinal Cord. 2016;54:1001\u20139.","journal-title":"Spinal Cord"},{"key":"7235_CR14","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1017\/ice.2017.238","volume":"38","author":"CT Evans","year":"2017","unstructured":"Evans CT, Fitzpatrick MA, Jones MM, Burns SP, Poggensee L, Ramanathan S, et al. Prevalence and factors associated with multidrug-resistant gram-negative organisms in patients with spinal cord injury. Infect Control Hosp Epidemiol. 2017;38:1464\u201371.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"7235_CR15","first-page":"332","volume":"6","author":"CS Forster","year":"2017","unstructured":"Forster CS, Courter J, Jackson EC, Mortensen JE, Haslam DB. Frequency of multidrug-resistant organisms cultured from urine of children undergoing clean intermittent catheterization. J Pediatric Infect Dis Soc. 2017;6:332\u20138.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"7235_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jmii.2013.05.006","volume":"47","author":"NC Fan","year":"2014","unstructured":"Fan NC, Chen HH, Chen CL, Ou LS, Lin TY, Tsai MH, et al. Rise of community-onset urinary tract infection caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in children. J Microbiol Immunol Infect. 2014;47:399\u2013405.","journal-title":"J Microbiol Immunol Infect"},{"key":"7235_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/ijpvm.IJPVM_419_17","volume":"10","author":"SAR Mortazavi-Tabatabaei","year":"2019","unstructured":"Mortazavi-Tabatabaei SAR, Ghaderkhani J, Nazari A, Sayehmiri K, Sayehmiri F, Pakzad I. Pattern of antibacterial resistance in urinary tract infections: a systematic review and meta-analysis. Int J Prev Med. 2019;10:169.","journal-title":"Int J Prev Med"},{"key":"7235_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1017\/ice.2016.60","volume":"37","author":"MA Fitzpatrick","year":"2016","unstructured":"Fitzpatrick MA, Suda KJ, Safdar N, Goldstein B, Jones MM, Poggensee L, et al. Unique risks and clinical outcomes associated with extended-spectrum \u03b2-lactamase enterobacteriaceae in veterans with spinal cord injury or disorder: a case\u2013case\u2013control study. Infect Control Hosp Epidemiol. 2016;37:768\u201376.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"7235_CR19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00345-015-1718-x","volume":"34","author":"L Toner","year":"2016","unstructured":"Toner L, Papa N, Aliyu SH, Dev H, Lawrentschuk N, Al-Hayek S. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years. World J Urol. 2016;34:1031\u20137.","journal-title":"World J Urol"},{"key":"7235_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajic.2018.08.001","volume":"47","author":"MA Fitzpatrick","year":"2019","unstructured":"Fitzpatrick MA, Suda KJ, Jones MM, Burns SP, Poggensee L, Ramanathan S, et al. Effect of varying federal definitions on prevalence and characteristics associated with carbapenem-resistant Enterobacteriaceae in veterans with spinal cord injury. Am J Infect Control. 2019;47:175\u20139.","journal-title":"Am J Infect Control"},{"key":"7235_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jhin.2005.07.013","volume":"62","author":"R Girard","year":"2006","unstructured":"Girard R, Mazoyer MA, Plauchu MM, Rode G. High prevalence of nosocomial infections in rehabilitation units accounted for by urinary tract infections in patients with spinal cord injury. J Hosp Infect. 2006;62:473\u20139.","journal-title":"J Hosp Infect"},{"key":"7235_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/10790268.2004.11752236","volume":"27","author":"KB Waites","year":"2004","unstructured":"Waites KB, Canupp KC, DeVivo MJ. Microbiology of the urethra and perineum and its relationship to bacteriuria in community-residing men with spinal cord injury. J Spinal Cord Med. 2004;27:448\u201352.","journal-title":"J Spinal Cord Med"},{"key":"7235_CR23","first-page":"356","volume":"20","author":"M Boolchandani","year":"2019","unstructured":"Boolchandani M, D\u2019Souza AW, Dantas G. Sequencing-based methods and resources to study antimicrobial resistance. Nat Rev Genet. 2019;20:356\u201370.","journal-title":"Nat Rev Genet"},{"key":"7235_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4111\/kju.2011.52.5.345","volume":"52","author":"KH Ryu","year":"2011","unstructured":"Ryu KH, Kim YB, Yang SO, Lee JK, Jung TY. Results of urine culture and antimicrobial sensitivity tests according to the voiding method over 10 years in patients with spinal cord injury. Korean J Urol. 2011;52:345\u20139.","journal-title":"Korean J Urol"},{"key":"7235_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.5535\/arm.2015.39.5.686","volume":"39","author":"MS Kang","year":"2015","unstructured":"Kang MS, Lee BS, Lee HJ, Hwang SW, Han ZA. Prevalence of and risk factors for multidrug-resistant bacteria in urine cultures of spinal cord injury patients. Ann Rehabil Med. 2015;39:686\u201395.","journal-title":"Ann Rehabil Med"},{"key":"7235_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0003-9993(00)90108-4","volume":"81","author":"KB Waites","year":"2000","unstructured":"Waites KB, Chen Y, DeVivo MJ, Canupp KC, Moser SA. Antimicrobial resistance in gram-negative bacteria isolated from the urinary tract in community-residing persons with spinal cord injury. Arch Phys Med Rehabil. 2000;81:764\u20139.","journal-title":"Arch Phys Med Rehabil"},{"key":"7235_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0003-9993(95)80615-6","volume":"76","author":"DD Cardenas","year":"1995","unstructured":"Cardenas DD, Hooton TM. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil. 1995;76:272\u201380.","journal-title":"Arch Phys Med Rehabil"},{"key":"7235_CR28","doi-asserted-by":"publisher","first-page":"E910","DOI":"10.1111\/j.1464-410X.2012.11549.x","volume":"110","author":"JJ Wyndaele","year":"2012","unstructured":"Wyndaele JJ, Brauner A, Geerlings SE, Bela K, Peter T, Bjerklund-Johanson TE. Clean intermittent catheterization and urinary tract infection: review and guide for future research. BJU Int. 2012;110:E910\u20137.","journal-title":"BJU Int"},{"key":"7235_CR29","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.pmrj.2011.01.001","volume":"3","author":"DD Cardenas","year":"2011","unstructured":"Cardenas DD, Moore KN, Dannels-McClure A, Scelza WM, Graves DE, Brooks M, et al. Intermittent catheterization with a hydrophilic-coated catheter delays urinary tract infections in acute spinal cord injury: a prospective, randomized, multicenter trial. Pm r. 2011;3:408\u201317.","journal-title":"Pm r"},{"key":"7235_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1086\/650482","volume":"50","author":"TM Hooton","year":"2010","unstructured":"Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625\u201363.","journal-title":"Clin Infect Dis"},{"key":"7235_CR31","doi-asserted-by":"crossref","unstructured":"Truzzi JC, de Almeida FG, Sacomani CA, Reis J, Rocha FET. Neurogenic bladder\u2014concepts and treatment recommendations. Int Braz J Urol. 2021;47.","DOI":"10.1590\/s1677-5538.ibju.2021.0098"},{"key":"7235_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sc.2014.10","volume":"52","author":"SB Yoon","year":"2014","unstructured":"Yoon SB, Lee BS, Lee KD, Hwang SI, Lee HJ, Han ZA. Comparison of bacterial strains and antibiotic susceptibilities in urinary isolates of spinal cord injury patients from the community and hospital. Spinal Cord. 2014;52:298\u2013301.","journal-title":"Spinal Cord"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07235-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T13:25:15Z","timestamp":1674912315000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07235-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7235"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07235-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1046860\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"3 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with Good Clinical Practices and the principles of the Declaration of Helsinki. The study was approved by the relevant Institutional Review Board of Krajsk\u00e1 nemocnice Liberec a.s. Written informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable<b>.<\/b>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}